Buprenorphine Tablet
Product Images NDC 87441-011

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 87441-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 2mg (Buprenorphine 2 mg)

Label for Buprenorphine Sublingual Tablets USP, 2 mg strength. The label includes dosage form and strength information, pharmacist dispensing instructions, storage conditions, and placeholders for lot number, expiration date, and quantity. It is repackaged by Unit Dose Solutions, Inc. and distributed by Tuckahoe Enterprises, LLC.*

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of buprenorphine, showing its molecular composition including various hydroxyl groups, methoxy group, and a cyclopropylmethyl substituent, indicated with the presence of hydrochloride (HCl).*

FDA Label Image

Image (Buprenorphine 02)

An instructional line drawing illustrating the placement of a sublingual tablet under the tongue. The image shows a hand positioning a round tablet beneath the tongue inside an open mouth, emphasizing the sublingual administration route for a tablet dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.